Vivacelle Bio, Inc. — Form D/A

Vivacelle Bio, Inc. of Evanston, IL, a company, filed a Form D amendment with the SEC on 2018-03-13. The offering totals $1.5M, of which $514K was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Stephen KeithDirectorToronto, A6
Krishna TalluriDirectorEvanston, IL
Stephen KeithExecutive OfficerToronto, A6
Paul BurtonDirectorChicago, IL
Paul BurtonExecutive OfficerChicago, IL
Cuthbert SimpkinsDirectorEvanston, IL
Cuthbert SimpkinsExecutive OfficerEvanston, IL
Ron DamperDirectorEvanston, IL
Diane SimpkinsDirectorEvanston, IL
Diane SimpkinsExecutive OfficerEvanston, IL
Krishna TalluriExecutive OfficerEvanston, IL
Harven DeShieldDirectorEvanston, IL
Harven DeShieldExecutive OfficerEvanston, IL
Ron Ormand DamperDirectorChicago, IL
Harven Ormand DeShieldDirectorChicago, IL
Harven Ormand DeShieldExecutive OfficerChicago, IL
Stephen Ormand KeithDirectorChicago, IL
Stephen Ormand KeithExecutive OfficerChicago, IL
Cuthbert Ormand SimpkinsDirectorChicago, IL
Cuthbert Ormand SimpkinsExecutive OfficerChicago, IL
Diane Ormand SimpkinsDirectorChicago, IL
Diane Ormand SimpkinsExecutive OfficerChicago, IL
Edward NicholsExecutive OfficerShreveport, LA

Other filings by this issuer (5)

FiledFormOfferingSold
2019-02-11D/A$3.4M$2.9M
2016-09-09D/A$1.3M$1.3M
2016-08-17D$1.5M$100K
2014-08-08D/A$550K$550K
2014-02-13D$1.0M$225K

More